Page 12 - Ampe D News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ampe d. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ampe D Today - Breaking & Trending Today
StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a research note published on Wednesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Up 7.9 % NYSEAMERICAN AMPE opened at $0.25 on Wednesday. The firm has a market cap of $3.83 million, a […] ....
StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a report published on Sunday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of AMPE stock opened at $0.24 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.18 and a 52 […] ....
A number of research firms have changed their ratings and price targets for Ampio Pharmaceuticals (NYSEAMERICAN: AMPE): 6/21/2023 – Ampio Pharmaceuticals is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 6/19/2023 – Ampio Pharmaceuticals is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. […] ....
The research houses Montega AG and NuWays AG by Hauck Aufhäuser Lampe have issued very favorable comments on the recent announcement of. | June 20, 2023 ....
Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE – Get Rating) was the target of a significant drop in short interest in May. As of May 31st, there was short interest totalling 446,900 shares, a drop of 40.3% from the May 15th total of 748,600 shares. Currently, 3.2% of the company’s stock are sold short. Based on an average […] ....